Array
(
[0] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1645591099:2
[_edit_last] => 1
[attributes] =>
[_attributes] => field_57879498f70b4
[item_content] => Rovista®EZ is a combination of rosuvastatin, an HMG CoA-reductase inhibitor (statin), and ezetimibe, a dietary cholesterol absorption inhibitor, indicated:
- as an adjunct to diet in patients with primary (heterozygous familial and non-familial) hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C)
- alone or as an adjuct to other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4305
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[generic_name] => Rosuvastatin + Ezetimibe
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Lipidemic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[_yoast_wpseo_estimated-reading-time-minutes] =>
[_yoast_wpseo_content_score] => 90
[getz_products_attributes_0_product_type] => Film-Coated Tablets
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 5mg + 10mg
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 3
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes_0_product_availability_1_products_strengths] => 10mg + 10mg
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 20mg + 10mg
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[_yoast_wpseo_primary_category] => 147
[_yoast_wpseo_primary_filters] => 66
[_yoast_wpseo_primary_countries] => 40
[_yoast_wpseo_metadesc] => Rovista®EZ is a combination of rosuvastatin, an HMG CoA-reductase inhibitor (statin), and ezetimibe, a dietary cholesterol absorption inhibitor, indicated: as an adjunct to diet in patients with primary (heterozygous familial and non-familial) hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C); alone or as an adjuct to other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C
[rank_math_primary_category] => 147
[rank_math_primary_filters] => 66
[rank_math_primary_countries] => 40
[rank_math_description] => Rovista®EZ is a combination of rosuvastatin, an HMG CoA-reductase inhibitor (statin), and ezetimibe, a dietary cholesterol absorption inhibitor, indicated: as an adjunct to diet in patients with primary (heterozygous familial and non-familial) hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C); alone or as an adjuct to other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C
[rank_math_news_sitemap_robots] => index
[rank_math_robots] => Array
(
[0] => index
)
[rank_math_analytic_object_id] => 4
[rank_math_internal_links_processed] => 1
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4303
[ID] => 4303
[post_author] => 1
[post_content] => Rovista®EZ is a combination of rosuvastatin, an HMG CoA-reductase inhibitor (statin), and ezetimibe, a dietary cholesterol absorption inhibitor, indicated:
- as an adjunct to diet in patients with primary (heterozygous familial and non-familial) hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C)
- alone or as an adjuct to other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C
[post_date] => 2022-02-21 05:48:33
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Rovista®EZ
[post_type] => product
[slug] => rovistaez
[__type:protected] =>
[_edit_lock] => 1645591099:2
[_edit_last] => 1
[attributes] =>
[_attributes] => field_57879498f70b4
[item_content] => Rovista®EZ is a combination of rosuvastatin, an HMG CoA-reductase inhibitor (statin), and ezetimibe, a dietary cholesterol absorption inhibitor, indicated:
- as an adjunct to diet in patients with primary (heterozygous familial and non-familial) hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C)
- alone or as an adjuct to other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4305
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[generic_name] => Rosuvastatin + Ezetimibe
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Lipidemic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[_yoast_wpseo_estimated-reading-time-minutes] =>
[_yoast_wpseo_content_score] => 90
[getz_products_attributes_0_product_type] => Film-Coated Tablets
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 5mg + 10mg
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 3
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes_0_product_availability_1_products_strengths] => 10mg + 10mg
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 20mg + 10mg
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[_yoast_wpseo_primary_category] => 147
[_yoast_wpseo_primary_filters] => 66
[_yoast_wpseo_primary_countries] => 40
[_yoast_wpseo_metadesc] => Rovista®EZ is a combination of rosuvastatin, an HMG CoA-reductase inhibitor (statin), and ezetimibe, a dietary cholesterol absorption inhibitor, indicated: as an adjunct to diet in patients with primary (heterozygous familial and non-familial) hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C); alone or as an adjuct to other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C
[rank_math_primary_category] => 147
[rank_math_primary_filters] => 66
[rank_math_primary_countries] => 40
[rank_math_description] => Rovista®EZ is a combination of rosuvastatin, an HMG CoA-reductase inhibitor (statin), and ezetimibe, a dietary cholesterol absorption inhibitor, indicated: as an adjunct to diet in patients with primary (heterozygous familial and non-familial) hyperlipidemia to reduce low-density lipoprotein cholesterol (LDL-C); alone or as an adjuct to other LDL-C lowering therapies in patients with homozygous familial hypercholesterolemia (HoFH) to reduce LDL-C
[rank_math_news_sitemap_robots] => index
[rank_math_robots] => Array
(
[0] => index
)
[rank_math_analytic_object_id] => 4
[rank_math_internal_links_processed] => 1
[post_date_gmt] => 2022-02-21 05:48:33
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => rovistaez
[to_ping] =>
[pinged] =>
[post_modified] => 2022-02-21 08:11:45
[post_modified_gmt] => 2022-02-21 08:11:45
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4303
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[1] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1708404359:1
[_edit_last] => 1
[getz_products_attributes_0_product_type] => Tablet
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 10MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 2
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4152
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] =>
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[attributes] =>
[_attributes] => field_57879498f70b4
[generic_name] => Rosuvastatin
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Lipidemic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[_yoast_wpseo_primary_countries] => 448
[_yoast_wpseo_content_score] => 30
[_yoast_wpseo_estimated-reading-time-minutes] => 2
[_yoast_wpseo_primary_category] => 450
[_yoast_wpseo_primary_filters] => 21
[rank_math_primary_countries] => 448
[rank_math_primary_category] => 450
[rank_math_primary_filters] => 21
[rank_math_news_sitemap_robots] => index
[rank_math_robots] => Array
(
[0] => index
)
[rank_math_analytic_object_id] => 23
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 9
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[getz_products_attributes_0_product_availability_1_products_strengths] => 20MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 4114
[ID] => 4114
[post_author] => 2
[post_content] => For the treatment of:
• Hyperlipidemia and mixed dyslipidemia as adjunctive therapy to diet to reduce elevated Total-C, LDL-C,
ApoB, nonHDL-C, and triglycerides and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. Lipid altering agents should be used in addition to a diet restricted in saturated fat and cholesterol when response to diet and nonpharmacological interventions alone has been inadequate.
• Pediatric patients 10 to 17 years of age with heterozygous familal hypercholesterolemia (HeFH) as adjunct to diet to reduce Total-C, LDL-C and ApoB levels in adolescent boys and girls, who are at least one year postmenarche, 10-17 years of age with heterozygous familial hypercholesterolemia if after an adequate trial of diet therapy the following findings are present: LDL-C greater than 190 mg/dL or greater than 160 mg/dL and there is a positive family his tory of premature cardiovascular disease (CVD) or two or more other CVD risk factors.
• Hypertriglyceridemia as adjunctive therapy to diet for the treatment of adult patients with
hypertriglyceridemia.
• Primary dysbetalipoproteinemia (Type III Hyperlipoproteinemia) as an adjunct to diet for the treatment of patients with primary dysbetalipoproteinemia (Type III Hyperlipoproteinemia).
• Homozygous familal hypercholesterolemia as adjunctive therapy to other lipid lowering treatments (e.g., LDL apheresis) or alone if such treatments are unavailable to reduce LDL-C, Total-C, and ApoB in adult patients with homozygous familial hypercholesterolemia.
• Slowing of the progression of atherosclerosis as adjunctive therapy to diet to slow the progression of atherosclerosis in adult patients as part of a treatment strategy to lower Total-C and LDL-C to target levels.
• Prevention of major cardiovascular events in patients who are estimated to have a high risk for a first cardiovascular event, as an adjunct to correction of other risk factors.
[post_date] => 2021-08-20 08:01:38
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Rovista™
[post_type] => product
[slug] => rovista-10
[__type:protected] =>
[_edit_lock] => 1708404359:1
[_edit_last] => 1
[getz_products_attributes_0_product_type] => Tablet
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 10MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 2
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 4152
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] =>
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[attributes] =>
[_attributes] => field_57879498f70b4
[generic_name] => Rosuvastatin
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Lipidemic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[_yoast_wpseo_primary_countries] => 448
[_yoast_wpseo_content_score] => 30
[_yoast_wpseo_estimated-reading-time-minutes] => 2
[_yoast_wpseo_primary_category] => 450
[_yoast_wpseo_primary_filters] => 21
[rank_math_primary_countries] => 448
[rank_math_primary_category] => 450
[rank_math_primary_filters] => 21
[rank_math_news_sitemap_robots] => index
[rank_math_robots] => Array
(
[0] => index
)
[rank_math_analytic_object_id] => 23
[rank_math_internal_links_processed] => 1
[rank_math_seo_score] => 9
[rank_math_contentai_score] => Array
(
[wordCount] => 100
[linkCount] => 0
[headingCount] => 100
[mediaCount] => 62.22
)
[getz_products_attributes_0_product_availability_1_products_strengths] => 20MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[post_date_gmt] => 2021-08-20 08:01:38
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => rovista-10
[to_ping] =>
[pinged] =>
[post_modified] => 2024-02-19 10:29:40
[post_modified_gmt] => 2024-02-19 10:29:40
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=4114
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
[2] => Timber\Post Object
(
[ImageClass] => Timber\Image
[PostClass] => Timber\Post
[TermClass] => Timber\Term
[object_type] => post
[custom] => Array
(
[_edit_lock] => 1579072230:2
[_edit_last] => 2
[getz_products_attributes_0_product_type] =>
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 5MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 10MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 20MG
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 3
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 3811
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] =>
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[attributes] =>
[_attributes] => field_57879498f70b4
[generic_name] => Rosuvastatin calcium
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Lipidemic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[_yoast_wpseo_primary_category] => 287
[_yoast_wpseo_primary_filters] => 19
[_yoast_wpseo_primary_countries] => 452
[_yoast_wpseo_content_score] => 30
[rank_math_primary_category] => 287
[rank_math_primary_filters] => 19
[rank_math_primary_countries] => 452
[rank_math_news_sitemap_robots] => index
[rank_math_robots] => Array
(
[0] => index
)
[rank_math_analytic_object_id] => 71
[rank_math_internal_links_processed] => 1
)
[___content:protected] =>
[_permalink:protected] =>
[_next:protected] => Array
(
)
[_prev:protected] => Array
(
)
[_css_class:protected] =>
[id] => 3810
[ID] => 3810
[post_author] => 2
[post_content] => As an adjunct to diet in primary hyperlipidemia and mixed dyslipidemia (Types IIa and IIb) to reduce elevated total-C, LDL-C, ApoB, non-HDL-C, and TG, and to increase HDL-C; Adjunct to diet in hypertriglyceridemia; adjunct to diet in primary dysbetalipoproteinemia (Type III hyperlipoproteinemia); adjunct to other lipid-lowering treatments (or if these treatments are unavailable), in homozygous familial hypercholesterolemia to reduce LDL-C, total-C, and ApoB; adjunct to diet to slow the progression of atherosclerosis as part of a treatment strategy to lower total-C and LDL-C to target levels.
[post_date] => 2020-01-13 06:11:11
[post_excerpt] =>
[post_parent] => 0
[post_status] => publish
[post_title] => Rovista
[post_type] => product
[slug] => rovista-8
[__type:protected] =>
[_edit_lock] => 1579072230:2
[_edit_last] => 2
[getz_products_attributes_0_product_type] =>
[_getz_products_attributes_0_product_type] => field_57aacd67c871f
[getz_products_attributes_0_product_availability_0_products_strengths] => 5MG
[_getz_products_attributes_0_product_availability_0_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_0_product_link] =>
[_getz_products_attributes_0_product_availability_0_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_1_products_strengths] => 10MG
[_getz_products_attributes_0_product_availability_1_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_1_product_link] =>
[_getz_products_attributes_0_product_availability_1_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability_2_products_strengths] => 20MG
[_getz_products_attributes_0_product_availability_2_products_strengths] => field_57aaccbd3b9c5
[getz_products_attributes_0_product_availability_2_product_link] =>
[_getz_products_attributes_0_product_availability_2_product_link] => field_5c0657259e1a3
[getz_products_attributes_0_product_availability] => 3
[_getz_products_attributes_0_product_availability] => field_57aacbc108025
[getz_products_attributes] => 1
[_getz_products_attributes] => field_57aacb9008024
[product_leaflet_text] => Prescribing Information
[_product_leaflet_text] => field_5858c3e8751a2
[product_leaflet] => 3811
[_product_leaflet] => field_58256525c3163
[multiple_leaflets] =>
[_multiple_leaflets] => field_5858c3fb751a3
[_] => field_5c41afb5d5896
[item_content] =>
[_item_content] => field_5770d187c6470
[item_image] =>
[_item_image] => field_5770d19cc6471
[attributes] =>
[_attributes] => field_57879498f70b4
[generic_name] => Rosuvastatin calcium
[_generic_name] => field_576e8d032aabe
[therapeutic_segment] => Anti-Lipidemic
[_therapeutic_segment] => field_577145185eefa
[redirector_active] => 0
[_redirector_active] => field_576392a2c282d
[recommended_articles] =>
[_recommended_articles] => field_5788f2cab8fde
[_yoast_wpseo_primary_category] => 287
[_yoast_wpseo_primary_filters] => 19
[_yoast_wpseo_primary_countries] => 452
[_yoast_wpseo_content_score] => 30
[rank_math_primary_category] => 287
[rank_math_primary_filters] => 19
[rank_math_primary_countries] => 452
[rank_math_news_sitemap_robots] => index
[rank_math_robots] => Array
(
[0] => index
)
[rank_math_analytic_object_id] => 71
[rank_math_internal_links_processed] => 1
[post_date_gmt] => 2020-01-13 06:11:11
[comment_status] => closed
[ping_status] => closed
[post_password] =>
[post_name] => rovista-8
[to_ping] =>
[pinged] =>
[post_modified] => 2020-01-15 07:12:40
[post_modified_gmt] => 2020-01-15 07:12:40
[post_content_filtered] =>
[guid] => https://getzpharma.com/?post_type=product&p=3810
[menu_order] => 0
[post_mime_type] =>
[comment_count] => 0
[filter] => raw
[status] => publish
)
)